Welltower Inc. (WELL) Stock Price & How to Invest

Welltower Inc. is the largest healthcare REIT in the world, owning a portfolio of senior housing, assisted living, post-acute and long-term care, and outpatient medical real estate across the United States, the United Kingdom, and Canada. It makes money in two main ways: through its Senior Housing Operating Portfolio (SHOP), where it shares directly in the net operating income that property operators generate from residents, and through rents on triple-net leased seniors housing and care facilities plus outpatient medical buildings. Because SHOP income flows through to Welltower rather than being fixed rent, rising occupancy and room rates translate quickly into higher earnings, which is why the operating portfolio has become the company's main growth engine.

Welltower traces its roots to 1970 and grew over decades into a diversified healthcare landlord before reshaping its portfolio around senior housing. The senior-housing sector was hit hard during the pandemic as occupancy fell, but it has staged a strong multi-year recovery as demand from an aging population outpaced limited new construction. That recovery accelerated through 2025: full-year normalized FFO reached $5.29 per share, up about 22.5% over 2024, revenue rose roughly 36% to about $10.84 billion, and in the fourth quarter the SHOP same-store portfolio grew net operating income about 20.4% year over year with occupancy near 89.5%. The company completed roughly $11 billion of net investments in 2025, continued to recycle capital out of outpatient medical, and is leaning on its Welltower Business System, an in-house operating and data platform, to push margins higher.

Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. The senior-housing operating model also carries labor cost and staffing pressures and depends on occupancy holding up, so a weaker demand environment or wage inflation could compress margins. The stock trades at a premium valuation relative to many healthcare REIT peers, which leaves limited room for disappointment and makes it vulnerable to multiple compression. The company is also deploying capital aggressively, so acquisition execution, integration, and the cost of financing that growth are real risks if returns on new investments fall short.

22 analysts publish price targets on WELL, averaging $252.41 against a $234.44 price as of August 2026, or +7.7%. The published targets run from $192.00 to $280.00, a moderate spread, and the ratings split 17 buy, 4 hold, 1 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full WELL forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Welltower Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Aging-demographics senior-housing tailwind. Welltower's central thesis is that the 80-plus population is growing rapidly while new senior-housing construction has stayed near multi-decade lows, creating a widening gap between demand and supply. The most optimistic published target, $280.00, assumes this works close to its best case.

The case against. Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. The most pessimistic target, $192.00, is roughly what WELL is worth if this bites instead.

Read the full bull and bear case on WELL, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Welltower Inc.'s investor relations page or your broker.

• Normalized FFO per share (2025): $5.29 (+~22.5%)
• 2026 normalized FFO guidance: $6.09 to $6.25
• SHOP same-store NOI growth (Q4 2025): ~20.4% YoY
• Revenue (2025): ~$10.84 billion (+~36%)
• SHOP occupancy (Q4 2025): ~89.5%
• Dividend (2026): $0.85/qtr (~$3.40/yr), yield ~1.5%
• Market cap: ~$145 billion

Healthcare REITs are valued on funds from operations (FFO) rather than EPS, because standard net income is weighed down by large non-cash depreciation charges on real estate. For Welltower the most important operating metric is same-store NOI growth in the Senior Housing Operating Portfolio, since that captures how much extra income the company earns as occupancy and room rates rise. Welltower trades at a notably higher FFO multiple, and a lower dividend yield, than most healthcare REIT peers, reflecting the market's confidence in its senior-housing growth, its scale, and its balance sheet; that premium is part of the investment case and part of the risk.

If you want WELL exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

These are the investment theses WELL naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to WELL: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get WELL exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (VNQ, SCHH, XLRE), which spreads the position across many companies. Or build it into a focused thematic portfolio, so WELL sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where WELL fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Welltower is a large-cap, S&P 500 healthcare REIT whose growth is tied to the aging-demographics tailwind in senior housing, where its operating portfolio has been posting double-digit same-store NOI growth. It tends to behave like an income-plus-growth real estate holding: a steadily rising dividend combined with earnings growth from senior-housing occupancy gains, with a share price that is sensitive to interest rates and to the premium valuation the market assigns it.

Whether WELL is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is WELL a buy or a sell?, and where the stock could go from here in the WELL stock forecast.

For income investors, whether WELL pays a dividend and how the payout looks is covered in does WELL pay a dividend? And to weigh WELL against a peer, read the full side-by-side comparisons: WELL vs AMT and WELL vs AVB.